The effects of serotonin3 receptor blockade on the psychobiological response to intravenous clomipramine in healthy human subjects

Biol Psychiatry. 1999 Jan 15;45(2):238-40. doi: 10.1016/s0006-3223(98)00045-6.

Abstract

Background: The purpose of this study was to determine the role that serotonin (5-HT)3 receptors play in the prolactin and nausea responses to clomipramine challenge.

Methods: Twenty healthy subjects were randomly assigned to pretreatment with either the selective 5-HT3 receptor antagonist ondansetron, or placebo, prior to intravenous infusion with clomipramine.

Results: Ondansetron pretreatment had no effect on the prolactin response to clomipramine challenge. There was a trend toward decreased nausea with ondansetron pre-treatment.

Conclusions: These findings are consistent with other data suggesting that 5-HT3 receptors do not play a major role in the prolactin response to 5-HT challenge in human subjects, but may mediate nausea associated with enhanced 5-HT neurotransmission.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Clomipramine / pharmacology*
  • Clomipramine / therapeutic use
  • Double-Blind Method
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Nausea / drug therapy
  • Ondansetron / therapeutic use
  • Prolactin / metabolism
  • Receptors, Serotonin / drug effects*
  • Serotonin Antagonists / pharmacology*
  • Serotonin Antagonists / therapeutic use

Substances

  • Receptors, Serotonin
  • Serotonin Antagonists
  • Ondansetron
  • Prolactin
  • Clomipramine